Browsing NTNU Open by Author "Solberg, Arne"
Now showing items 1-14 of 14
-
Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953–2015: A population-based prospective cohort study
Kvammen, Øivind; Myklebust, Tor Åge; Solberg, Arne; Møller, Bjørn; Klepp, Olbjørn; Fosså, Sophie Dorothea; Tandstad, Torgrim (Journal article; Peer reviewed, 2019)Background Testicular germ cell tumor (TGCT) patients and survivors have excess mortality compared to the general male population, but relative survival (RS) has been scarcely studied. We investigated causes of excess ... -
Detection of recurrent prostate cancer with 18F-Fluciclovine PET/MRI
Selnæs, Kirsten Margrete; Krüger-Stokke, Brage; Elschot, Mattijs; Johansen, Håkon; Steen, Per Arvid; Langørgen, Sverre; Aksnessæther, Bjørg Yksnøy; Indrebø, Gunnar; Sjøbakk, Torill Eidhammer; Tessem, May-Britt; Moestue, Siver Andreas; Knobel, Heidi; Tandstad, Torgrim; Bertilsson, Helena; Solberg, Arne; Bathen, Tone Frost (Peer reviewed; Journal article, 2020)Objective: Simultaneous PET/MRI combines soft-tissue contrast of MRI with high molecular sensitivity of PET in one session. The aim of this prospective study was to evaluate detection rates of recurrent prostate cancer by ... -
Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?
Aksnessæther, Bjørg Yksnøy; Solberg, Arne; Klepp, Olbjørn; Myklebust, Tor Åge; Skovlund, Eva; Hoff, Solveig Roth; Vatten, Lars Johan; Lund, Jo-Åsmund (Journal article; Peer reviewed, 2018)Purpose Prostate cancer (PC) patients who undergo antiandrogen monotherapy are offered prophylactic radiation therapy (PRT) to the breast buds to avoid gynecomastia. The aim of the present study was to evaluate whether ... -
Dose to penile bulb is not associated with erectile dysfunction 18 months post radiotherapy: A secondary analysis of a randomized trial
Tøndel, Hanne; Lund, Jo-Åsmund; Lydersen, Stian; Wanderås, Anne Dybdahl; Aksnessæther, Bjørg Yksnøy; Jensen, Christer André; Kaasa, Stein; Solberg, Arne (Journal article; Peer reviewed, 2018)Background Erectile dysfunction is a common side effect of prostate cancer (PC) therapy. In this randomized study (The RIC-study) we used patient reported outcomes to evaluate sexual function 18 months after combined ... -
Image-Guided Radiotherapy for Prostate Cancer and Side Effects after Treatment
Tøndel, Hanne (Doctoral theses at NTNU;2019:62, Doctoral thesis, 2019)Norsk sammendrag Prostatakreft er den vanligste kreftsykdommen blant norske menn med nesten 5000 nye tilfeller diagnostisert i 2016. Prognosen ved lokalisert sykdom er god og samlet 5-års overlevelse er nå godt over 90%. ... -
Interventions and symptom relief in hospital palliative cancer care: results from a prospective longitudinal study
Thronæs, Morten; Løhre, Erik T; Kvikstad, Anne; Brenne, Elisabeth; Norvaag, Robin; Aalberg, Kathrine Otelie; Moen, Martine Kjølberg; Jakobsen, Gunnhild; Klepstad, Pål; Solberg, Arne; Solheim, Tora S (Journal article; Peer reviewed, 2021)Purpose To study the use of interventions and symptom relief for adult patients with incurable cancer admitted to an acute palliative care unit providing integrated oncology and palliative care services. Methods All ... -
Outcome Assessments in Non- Metastatic Prostate Cancer
Solberg, Arne (Doktoravhandlinger ved NTNU, 1503-8181; 2011:74, Doctoral thesis, 2011)Metoder for å måle utfall av behandling hos pasienter med prostatakreft uten spredning. Prostatakreft uten påvist spredning kan behandles med operasjon, strålebehandling med eller uten hormonbehandling, eller hormonbehandling ... -
Radiotherapy for prostate cancer – Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial
Tøndel, Hanne; Lund, Jo-Åsmund; Lydersen, Stian; Wanderås, Anne Dybdahl; Aksnessæther, Bjørg Yksnøy; Jensen, Christer André; Kaasa, Stein; Solberg, Arne (Journal article; Peer reviewed, 2018)Background Novel cancer drugs are subject to strict scientific evaluation of safety and efficacy and usually undergo a cost effectiveness analysis before approval for use in clinical practice. For new techniques in ... -
Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer
Tøndel, Hanne; Solberg, Arne; Lydersen, Stian; Jensen, Christer André; Kaasa, Stein; Lund, Jo-Åsmund (Journal article; Peer reviewed, 2019)The introduction of modern image-guided radiotherapy (IGRT) has given new insight regarding organ motion in radiotherapy (RT), both in general and in treatment for prostate cancer (PC) [1]. IGRT with daily Cone-beam computed ... -
Relative Survival and Second Cancer Risk after Diagnosis of Testicular Germ Cell Tumor
Kvammen, Øivind (Doctoral theses at NTNU;2022:76, Doctoral thesis, 2022)Norsk sammendrag Testikkelkreft (TC) er den vanligste kreftformen blant yngre menn, med omtrent 300 årlige tilfeller i Norge. Nesten alle TC-tilfeller er testikulære germinalcellesvulster, som igjen inndeles i seminomer ... -
Second cancers after prostate cancer treatment
Aksnessæther, Bjørg Yksnøy (Doctoral theses at NTNU;2021:354, Doctoral thesis, 2021)Ny kreftsykdom etter behandling for prostatakreft. Sekundær kreft er et økende helseproblem over hele verden. De to viktigste årsakene er økt forventet levealder og økt overlevelse etter den første kreftsykdommen. ... -
Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial
Aksnessæther, Bjørg Yksnøy; Myklebust, Tor Åge; Solberg, Arne; Klepp, Olbjørn; Skovlund, Eva; Hoff, Solveig Roth; Fosså, Sophie Dorothea; Widmark, Anders; Lund, Jo-Åsmund (Peer reviewed; Journal article, 2019)Background Curative radiation therapy (RT) constitutes a cornerstone in prostate cancer (PC) treatment. We present long-term follow-up estimates for second cancer (SC) risk and overall survival (OS) in patients randomized ... -
Second cancers in radically treated Norwegian prostate cancer patients
Aksnessæther, Bjørg Yksnøy; Lund, Jo-Åsmund; Myklebust, Tor Åge; Klepp, Olbjørn; Skovlund, Eva; Hoff, Solveig Roth; Solberg, Arne (Journal article; Peer reviewed, 2019)Introduction: The aim of this registry-based cohort study was to estimate second cancer (SC) risk following radical prostate cancer (PC) treatment and evaluate if the risk was influenced by radiotherapy. Materials and ... -
Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study
Haugnes, Hege S.; Negaard, Helene F.; Negaard, Helene Francisca Stigter; Jensvoll, Hilde; Wilsgaard, Tom; Tandstad, Torgrim; Solberg, Arne (Peer reviewed; Journal article, 2021)Background Cisplatin-based chemotherapy (CBCT) in testicular cancer (TC) is associated with elevated venous thromboembolism (VTE) risk, but trials evaluating the safety and efficacy of thromboprophylaxis are lacking. ...